Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
Running, not enrolling · Phase 2/Phase 3
Conditions studied: Alopecia Areata
In brief
The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate to severe alopecia areata.
Key facts
- Study ID
- NCT03898479
- Run by
- Sun Pharmaceutical Industries, Inc.
- People needed
- 1000
- Starts
- 2019-04-04
- Expected to finish
- 2027-06-01
- Last updated by the study team
- 2025-10-22
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Have completed 24 weeks of treatment in a previous qualifying CTP-543 clinical trial
You may not qualify if…
- Active scalp inflammation, psoriasis, or seborrheic dermatitis requiring topical treatment to the scalp, significant trauma to the scalp, or untreated actinic keratosis
- Females who are nursing, pregnant, or planning to become pregnant while in the study, and for 30 days after last dose of study medication
- Donation of blood at any point throughout the study and for 30 days after last dose of study medication
Where it is running
- Alliance Dermatology & MOHS Center — Phoenix, Arizona, United States
- Center for Dermatology and Plastic Surgery/CCT Research — Scottsdale, Arizona, United States
- Johnson Dermatology — Fort Smith, Arkansas, United States
- Northwest Arkansas Clinical Trials Center, PLLC — Rogers, Arkansas, United States
- Kern Research Inc. — Bakersfield, California, United States
- Hope Clinical Research — Canoga Park, California, United States
- California Dermatology & Clinical Research Institute — Encinitas, California, United States
- University of California, Irvine — Irvine, California, United States
- Dermatology Research Associates — Los Angeles, California, United States
- Quest Dermatology Research — Northridge, California, United States
- Kaiser Permanente Northern California - Oakland — Oakland, California, United States
- Palmtree Clinical Research, Inc. — Palm Springs, California, United States
- Stanford University School of Medicine - Medical Dermatology Clinic — Redwood City, California, United States
- Kaiser Permanente South Sacramento — Sacramento, California, United States
- Kaiser Permanente Clinical Trials Unit — San Francisco, California, United States
- Colorado Center for Dermatology, PLLC d/b/a CODerm Research — Centennial, Colorado, United States
- Colorado Medical Research Center — Denver, Colorado, United States
- Yale University Church Street Research Unit — New Haven, Connecticut, United States
- Skin Care Research, LLC — Boca Raton, Florida, United States
- Skin Care Research, LLC — Hollywood, Florida, United States
- University of Miami Hospital — Miami, Florida, United States
- Floridian Research Institute, LLC — Miami, Florida, United States
- Lenus Research & Medical Group, LLC — Sweetwater, Florida, United States
- Clinical Research Trials of Florida, Inc. — Tampa, Florida, United States
- Total Skin and Beauty Dermatology Center — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.